Demonstrates improved performance of engineered ω-transaminase for bulky chiral amines, highlighting its potential applications.
A mechanism-guided strategy weighting two key reaction states, the prereaction conformation and external aldimine, enabled rational engineering of a novel ω-transaminase ATA-116 for bulky chiral amines. Two residues, W57F and R390S, were identified, showing 210- and 107-fold improvements in k cat / K m, respectively (>99% ee). The highest conversion reached 91% (2.5% for the wild type). The strategy also expanded the substrate scope across 15 indanone derivatives and improved thermostability. Molecular dynamics simulations elucidated the mechanistic basis.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: